- Corporate Officers - V
- Vivo Capital Surplus Fund Viii, L.p.
Insider Trading History of Vivo Capital Surplus Fund Viii, L.p.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Vivo Capital Surplus Fund Viii, L.p. since 2020.
This trader's CIK number is 1628048.
At the time of last reporting, Vivo Capital Surplus Fund Viii, L.p. was the Officer of Terns Pharmaceuticals, Inc.. (stock ticker symbol TERN).
Also see all insider trading activities at Terns Pharmaceuticals, Inc..
Note that in the past
Vivo Capital Surplus Fund VIII, L.P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Crinetics Pharmaceuticals, Inc. (CRNX) by Vivo Capital Surplus Fund Viii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | CRNX | 0 | $0 | 636,713 | $9,333,585 | 0 | $0 |
Yearly summary of insider trading at Terns Pharmaceuticals, Inc. (TERN) by Vivo Capital Surplus Fund Viii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TERN | 0 | $0 | 420,663 | $2,796,858 | 0 | $0 |
| 2022 | TERN | 3,982,859 | $14,640,238 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Impel Pharmaceuticals Inc (IMPL) by Vivo Capital Surplus Fund Viii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | IMPL | 0 | $0 | 575,000 | $74,130 | 0 | $0 |
| 2021 | IMPL | 575,000 | $8,625,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aligos Therapeutics, Inc. (ALGS) by Vivo Capital Surplus Fund Viii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ALGS | 550,000 | $8,250,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Vivo Capital Surplus Fund Viii, L.p.:
1. Crinetics Pharmaceuticals, Inc. (CRNX)
2. Terns Pharmaceuticals, Inc. (TERN)
3. Impel Pharmaceuticals Inc (IMPL)
4. Aligos Therapeutics, Inc. (ALGS)
Table 1. Insider trading of Crinetics Pharmaceuticals, Inc. (CRNX) by Vivo Capital Surplus Fund Viii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-04-16 | CRNX | Sale | 30,190 | 15.20 | 458,888 |
| 2020-04-17 | CRNX | Sale | 84,598 | 15.40 | 1,302,809 |
| 2020-04-15 | CRNX | Sale | 215,810 | 15.50 | 3,345,055 |
| 2020-04-07 | CRNX | Sale | 6,115 | 14.20 | 86,833 |
| 2020-04-03 | CRNX | Sale | 300,000 | 13.80 | 4,140,000 |
Table 2. Insider trading of Terns Pharmaceuticals, Inc. (TERN) by Vivo Capital Surplus Fund Viii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-04-01 | TERN | Sale | 181,117 | 6.99 | 1,266,007 |
| 2024-04-02 | TERN | Sale | 101,480 | 6.65 | 674,842 |
| 2024-04-03 | TERN | Sale | 138,066 | 6.20 | 856,009 |
| 2022-12-23 | TERN | Buy | 758,620 | 7.25 | 5,499,995 |
| 2022-09-07 | TERN | Buy | 600,000 | 3.60 | 2,160,000 |
| 2022-08-12 | TERN | Buy | 1,123,021 | 2.98 | 3,346,602 |
| 2022-08-15 | TERN | Buy | 1,218 | 2.99 | 3,641 |
| 2022-08-16 | TERN | Buy | 1,500,000 | 2.42 | 3,630,000 |
Table 3. Insider trading of Impel Pharmaceuticals Inc (IMPL) by Vivo Capital Surplus Fund Viii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-15 | IMPL | Sale | 100,000 | .29 | 28,999 |
| 2023-12-18 | IMPL | Sale | 237,711 | .11 | 26,148 |
| 2023-12-19 | IMPL | Sale | 237,289 | .08 | 18,983 |
| 2021-04-27 | IMPL | Buy | 575,000 | 15.00 | 8,625,000 |
Table 4. Insider trading of Aligos Therapeutics, Inc. (ALGS) by Vivo Capital Surplus Fund Viii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-10-20 | ALGS | Buy | 550,000 | 15.00 | 8,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Vivo Capital Surplus Fund Viii, L.p.
(Officer of Terns Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.